These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10949985)
1. Hepatotoxicity of camptothecin derivatives in a primary culture system of rat hepatocytes. Fulco RA; Costa C; Germanò MP; Torre EA; Viscomi MG; Salimbeni V; Maisano R; Giudice A; Costa G J Chemother; 2000 Aug; 12(4):345-51. PubMed ID: 10949985 [TBL] [Abstract][Full Text] [Related]
2. N-deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. Rodriguez RJ; Acosta D Toxicology; 1997 Feb; 117(2-3):123-31. PubMed ID: 9057891 [TBL] [Abstract][Full Text] [Related]
3. Camptothecin analogues with enhanced antitumor activity at acidic pH. Adams DJ; Dewhirst MW; Flowers JL; Gamcsik MP; Colvin OM; Manikumar G; Wani MC; Wall ME Cancer Chemother Pharmacol; 2000; 46(4):263-71. PubMed ID: 11052623 [TBL] [Abstract][Full Text] [Related]
4. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis. Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760 [TBL] [Abstract][Full Text] [Related]
5. The current status of camptothecin analogues as antitumor agents. Slichenmyer WJ; Rowinsky EK; Donehower RC; Kaufmann SH J Natl Cancer Inst; 1993 Feb; 85(4):271-91. PubMed ID: 8381186 [TBL] [Abstract][Full Text] [Related]
6. Biliary excretion mechanism of CPT-11 and its metabolites in humans: involvement of primary active transporters. Chu XY; Kato Y; Ueda K; Suzuki H; Niinuma K; Tyson CA; Weizer V; Dabbs JE; Froehlich R; Green CE; Sugiyama Y Cancer Res; 1998 Nov; 58(22):5137-43. PubMed ID: 9823324 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of camptothecin nanosuspension: a novel formulation with high antitumor efficacy and low toxicity. Yao L; Zhao X; Li Q; Zu Y; Fu Y; Zu B; Meng X; Liu C Int J Pharm; 2012 Feb; 423(2):586-8. PubMed ID: 22193057 [TBL] [Abstract][Full Text] [Related]
8. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity. Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251 [TBL] [Abstract][Full Text] [Related]
9. Comparison of ketoconazole- and fluconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. Rodriguez RJ; Acosta D Toxicology; 1995 Feb; 96(2):83-92. PubMed ID: 7886687 [TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic potential of camptothecin and topotecan. Clements MK; Jones CB; Cumming M; Daoud SS Cancer Chemother Pharmacol; 1999; 44(5):411-6. PubMed ID: 10501915 [TBL] [Abstract][Full Text] [Related]
11. In vitro sensitivity of fresh ovarian carcinoma specimens to CPT-11 (irinotecan). O'meara AT; Sevin BU Gynecol Oncol; 1999 Feb; 72(2):143-7. PubMed ID: 10021292 [TBL] [Abstract][Full Text] [Related]
12. Novel Hydrophilic Camptothecin Derivatives Conjugated to Branched Glycerol Trimer Suppress Tumor Growth without Causing Diarrhea in Murine Xenograft Models of Human Lung Cancer. Tsuchihashi Y; Abe S; Miyamoto L; Tsunematsu H; Izumi T; Hatano A; Okuno H; Yamane M; Yasuoka T; Ikeda Y; Tsuchiya K Mol Pharm; 2020 Apr; 17(4):1049-1058. PubMed ID: 32068412 [TBL] [Abstract][Full Text] [Related]
13. Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH. Gabr A; Kuin A; Aalders M; El-Gawly H; Smets LA Cancer Res; 1997 Nov; 57(21):4811-6. PubMed ID: 9354443 [TBL] [Abstract][Full Text] [Related]
14. [Camptothecin and derivatives: a new class of antitumor agents]. Torck M; Pinkas M J Pharm Belg; 1996; 51(4):200-7. PubMed ID: 8965250 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues. Li Q; Zu Y; Shi R; Yao L; Fu Y; Yang Z; Li L Bioorg Med Chem; 2006 Nov; 14(21):7175-82. PubMed ID: 16870453 [TBL] [Abstract][Full Text] [Related]
16. Pre-clinical evaluation of SN-38 and novel camptothecin analogs against human chronic B-cell lymphocytic leukemia lymphocytes. Cohen DP; Adams DJ; Flowers JL; Wall ME; Wani MC; Manikumar G; Colvin OM; Silber R Leuk Res; 1999 Nov; 23(11):1061-70. PubMed ID: 10576512 [TBL] [Abstract][Full Text] [Related]
17. Caffeine potentiation of allyl alcohol-induced hepatotoxicity. II. In vitro study. Karas M; Chakrabarti SK J Environ Pathol Toxicol Oncol; 2001; 20(2):155-64. PubMed ID: 11394714 [TBL] [Abstract][Full Text] [Related]
18. Involvement of apoptosis in hydrazine induced toxicity in rat primary hepatocytes. Hussain SM; Frazier JM Toxicol In Vitro; 2003 Jun; 17(3):343-55. PubMed ID: 12781213 [TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective potential of astaxanthin against 2,3,7,8-tetrachlorodibenzo-p-dioxin in cultured rat hepatocytes. Turkez H; Geyikoglu F; Yousef MI; Togar B; Gürbüz H; Celik K; Akbaba GB; Polat Z Toxicol Ind Health; 2014 Mar; 30(2):101-12. PubMed ID: 22778115 [TBL] [Abstract][Full Text] [Related]
20. RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells. Wang X; Lu X; Zhou G; Lou H; Luo G Biosci Rep; 2011 Oct; 31(5):363-9. PubMed ID: 21210765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]